Long-term calibration considerations during subcutaneous microdialysis sampling in mobile rats

Biomaterials

Volumn 31, Issue 16, 2010, Pages 4530-4539

  Mou, Xiaodun ^a   Lennartz, Michelle R ^b   Loegering, Daniel J ^b   Stenken, Julie A ^c  

^a Rensselaer Polytechnic Institute   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c UNIVERSITY OF ARKANSAS   (United States)

Author keywords

Antipyrine; Calibration; Foreign body reaction; Glucose; In vivo microdialysis sampling

Indexed keywords

ENDOGENOUS GLUCOSE; EXTRACTION EFFICIENCIES; FOREIGN BODY REACTIONS; GLUCOSE CONCENTRATION; HISTOLOGICAL ANALYSIS; IN-VIVO; INFLAMMATORY RESPONSE; INTERNAL STANDARDS; LOCALIZED DELIVERY; LOW-MOLECULAR WEIGHT SOLUTES; MEMBRANE EXTRACTION; MICRODIALYSIS PROBE; MICRODIALYSIS SAMPLING; POLYETHERSULFONES; POST-IMPLANTATION; RESEARCH AREAS; SAMPLING DEVICES; SPRAGUE-DAWLEY RATS; VITAMIN B;

CALIBRATION; EXTRACTION; GALERKIN METHODS; GLUCOSE; PROBES; RATS;

DIALYSIS;

CYANOCOBALAMIN; DEOXYGLUCOSE; GLUCOSE; PHENAZONE; POLYCARBONATE; POLYETHER; POLYETHERSULFONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALIBRATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FOREIGN BODY REACTION; HISTOLOGY; IMPLANT; IN VIVO STUDY; MEMBRANE COMPONENT; MICRODIALYSIS; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPYRINE; BIOSENSING TECHNIQUES; CALIBRATION; DEOXYGLUCOSE; GLUCOSE; IMPLANTS, EXPERIMENTAL; INJECTIONS, SUBCUTANEOUS; MICRODIALYSIS; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN B 12;

RATTUS;

EID: 77950038667     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.02.016     Document Type: Article

References (46)

1. In vivo glucose sensors 2010, John Wiley & Sons, Hoboken, NJ. D.D. Cunningham, J.A. Stenken (Eds.).
2. Skyler J.S. Continuous glucose monitoring: an overview of its development. Diabetes Technol Ther 2009, 11:S5-S10.
3. Iyer S.S., Barr W.H., Karnes H.T. Profiling in vitro drug release from subcutaneous implants: a review of current status and potential implications on drug product development. Biopharm Drug Dispos 2006, 27:157-170.
4. Coleman D.L., King R.N., Andrade J.D. The foreign body reaction: a chronic inflammatory response. J Biomed Mater Res 1974, 8:199-211.
5. Anderson J.M., Rodriguez A., Chang D.T. Foreign body reaction to biomaterials. Semin Immunol 2008, 20:86-100.
6. Ratner B.D., Bryant S.J. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng 2004, 6:41-75.
7. Gifford R., Kehoe J.J., Barnes S.L., Kornilayev B.A., Alterman M.A., Wilson G.S. Protein interactions with subcutaneously implanted biosensors. Biomaterials 2006, 27:2587-2598.
8. Dungel P., Long N., Yu B., Moussy Y., Moussy F. Study of the effects of tissue reactions on the function of implanted glucose sensors. J Biomed Mater Res Part A 2008, 85A:699-706.
9. Koschwanez H.E., Reichert W.M. In vitro, in vivo and post explantation testing of glucose-detecting biosensors: current methods and recommendations. Biomaterials 2007, 28:3687-3703.
10. Voskerician G., Shive M.S., Shawgo R.S., von Recum H., Anderson J.M., Cima M.J., et al. Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials 2003, 24:1959-1967.
11. Wang J. Electrochemical glucose biosensors. Chem Rev 2007, 108:814-825.
12. Quinn C.A.P., Connor R.E., Heller A. Biocompatible, glucose-permeable hydrogel for in situ coating of implantable biosensors. Biomaterials 1997, 18:1665-1670.
13. Ju Y.M., Yu B., Koob T.J., Moussy Y., Moussy F. A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. I. In vitro/in vivo stability of the scaffold and in vitro sensitivity of the glucose sensor with scaffold. J Biomed Mater Res Part A 2008, 87A:136-146.
14. Ju Y.M., Yu B., West L., Moussy Y., Moussy F. A novel porous collagen scaffold around an implantable biosensor for improving biocompatibility. II. Long-term in vitro/in vivo sensitivity characteristics of sensors with NDGA- or GA-crosslinked collagen scaffolds. J Biomed Mater Res Part A 2010, 92A:650-658.
15. Geelhood S.J., Horbett T.A., Ward W.K., Wood M.D., Quinn M.J. Passivating protein coatings for implantable glucose sensors: evaluation of protein retention. J Biomed Mater Res Part B: Appl Biomater 2007, 81:251-260.
16. Frost M., Meyerhoff M.E. In vivo chemical sensors: tackling biocompatibility. Anal Chem 2006, 78:7370-7377.
17. Ward W.K., Wood M.D., Casey H.M., Quinn M.J., Federiuk I.F. The effect of local subcutaneous delivery of vascular endothelial growth factor on the function of a chronically implanted amperometric glucose sensor. Diabetes Technol Ther 2004, 6:137-145.
18. Hickey T., Kreutzer D., Burgess D.J., Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 2002, 23:1649-1656.
19. Hetrick E.M., Prichard H.L., Klitzman B., Schoenfisch M.H. Reduced foreign body response at nitric oxide-releasing subcutaneous implants. Biomaterials 2007, 28:4571-4580.
20. Klueh U., Dorsky D.I., Kreutzer D.L. Enhancement of implantable glucose sensor function in vivo using gene transfer-induced neovascularization. Biomaterials 2005, 26:1155-1163.
21. Handbook of microdialysis sampling: methods, applications, and clinical aspects 2007, Academic Press, Amsterdam. B.H.C. Westerink, T.I.F.H. Cremers (Eds.).
22. Nandi P., Lunte S.M. Recent trends in microdialysis sampling integrated with conventional and microanalytical systems for monitoring biological events: a review. Anal Chim Acta 2009, 651:1-14.
23. Wisniewski N., Klitzman B., Miller B., Reichert W.M. Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. J Biomed Mater Res 2001, 57:513-521.
24. Ricci F., Moscone D., Palleschi G. Ex vivo continuous glucose monitoring with microdialysis technique: the example of GlucoDay. IEEE Sens J 2008, 8:63-70.
25. Bungay P.M., Morrison P.F., Dedrick R.L. Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro. Life Sci 1990, 46:105-119.
26. Bungay P.M., Newton-Vinson P., Isele W., Garris P.A., Justice J.B. Microdialysis of dopamine interpreted with quantitative model incorporating probe implantation trauma. J Neurochem 2003, 86:932-946.
27. Stenken J.A. Methods and issues in microdialysis calibration. Anal Chim Acta 1999, 379:337-357.
28. Wick A.N., Drury D.R., Nakada H.I., Wolfe J.B. Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem 1957, 224:963-969.
29. Mou X., Stenken J.A. Microdialysis sampling extraction efficiency of 2-deoxyglucose: role of macrophages in vitro and in vivo. Anal Chem 2006, 78:7778-7784.
30. Deguchi Y., Terasaki T., Kawasaki S., Tsuji A. Muscle microdialysis as a model study to relate the drug concentration in tissue interstitial fluid and dialysate. J Pharmacobiodyn 1991, 14:483-492.
31. Yokel R.A., Allen D.D., Burgio D.E., McNamara P.J. Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis. J Pharmacol Toxicol Methods 1992, 27:135-142.
32. Haraldsson B., Rippe B. Upper and lower bounds on capillary permeability ratios of Cr-EDTA to cyanocobalamin in rat hindquarters. Acta Physiol Scand 1991, 143:239-241.
33. Sharkawy A.A., Klitzman B., Truskey G.A., Reichert W.M. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res 1997, 37:401-412.
34. Sharkawy A.A., Klitzman B., Truskey G.A., Reichert W.M. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res 1998, 40:586-597.
35. Sharkawy A.A., Klitzman B., Truskey G.A., Reichert W.M. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J Biomed Mater Res 1998, 40:598-605.
36. Schutte R.J., Oshodi S.A., Reichert W.M. In vitro characterization of microdialysis sampling of macromolecules. Anal Chem 2004, 76:6058-6063.
37. Bancroft J., Gamble M. Theory and practice of histological techniques 2001, Churchill Livingstone, London.
38. Gilligan B.C., Shults M., Rhodes R.K., Jacobs P.G., Brauker J.H., Pintar T.J., et al. Feasibility of continuous long-term glucose monitoring from a subcutaneous glucose sensor in humans. Diabetes Technol Ther 2004, 6:378-386.
39. Pickup J.C., Hussain F., Evans N.D., Sachedina N. In vivo glucose monitoring: the clinical reality and the promise. Biosens Bioelectron 2005, 20:1897-1902.
40. Rebrin K., Fischer U., Hahn von Dorsche H., von Woetke T., Abel P., Brunstein E. Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality?. J Biomed Eng 1992, 14:33-40.
41. Ward W.K., Jansen L.B., Anderson E., Reach G., Klein J.-C., Wilson G.S. A new amperometric glucose microsensor: in vitro and short-term in vivo evaluation. Biosens Bioelectron 2002, 17:181-189.
42. Henninger N., Woderer S., Kloetzer H.-M., Staib A., Gillen R., Li L., et al. Tissue response to subcutaneous implantation of glucose-oxidase-based glucose sensors in rats. Biosens Bioelectron 2007, 23:26-34.
43. Clark H., Barbari T.A., Stump K., Rao G. Histologic evaluation of the inflammatory response around implanted hollow fiber membranes. J Biomed Mater Res 2000, 52:183-192.
44. Groth L., Jorgensen A., Serup J. Cutaneous microdialysis in the rat: insertion trauma and effect of anaesthesia studied by laser Doppler perfusion imaging and histamine release. Skin Pharmacol Appl Skin Physiol 1998, 11:125-132.
45. Mathy F.X., Denet A.R., Vroman B., Clarys P., Barel A., Verbeeck R.K., et al. In vivo tolerance assessment of skin after insertion of subcutaneous and cutaneous microdialysis probes in the rat. Skin Pharmacol Appl Skin Physiol 2003, 16:18-27.
46. Wang X., Lennartz M.R., Loegering D.J., Stenken J.A. Interleukin-6 collection through long-term implanted microdialysis sampling probes in rat subcutaneous space. Anal Chem 2007, 79:1816-1824.